Mohammed Almannai

1.8k total citations
43 papers, 935 citations indexed

About

Mohammed Almannai is a scholar working on Molecular Biology, Clinical Biochemistry and Genetics. According to data from OpenAlex, Mohammed Almannai has authored 43 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 23 papers in Clinical Biochemistry and 11 papers in Genetics. Recurrent topics in Mohammed Almannai's work include Metabolism and Genetic Disorders (23 papers), Mitochondrial Function and Pathology (20 papers) and Diet and metabolism studies (6 papers). Mohammed Almannai is often cited by papers focused on Metabolism and Genetic Disorders (23 papers), Mitochondrial Function and Pathology (20 papers) and Diet and metabolism studies (6 papers). Mohammed Almannai collaborates with scholars based in Saudi Arabia, United States and United Arab Emirates. Mohammed Almannai's co-authors include Ayman W. El‐Hattab, Fernando Scaglia, V. Reid Sutton, Majid Alfadhel, Jehan Suleiman, Ronit Marom, William J. Craigen, Claudia Soler‐Alfonso, Eissa Faqeih and Farook Jahoor and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Human Genetics and Clinical Chemistry.

In The Last Decade

Mohammed Almannai

40 papers receiving 917 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammed Almannai Saudi Arabia 17 597 381 137 125 88 43 935
Shlomo Almashanu Israel 16 390 0.7× 271 0.7× 136 1.0× 128 1.0× 62 0.7× 45 838
Zuhair N. Al‐Hassnan Saudi Arabia 18 549 0.9× 291 0.8× 248 1.8× 166 1.3× 44 0.5× 78 1.0k
Martin Magner Czechia 17 493 0.8× 287 0.8× 103 0.8× 180 1.4× 97 1.1× 64 892
Ali Dursun Türkiye 17 434 0.7× 438 1.1× 145 1.1× 215 1.7× 88 1.0× 97 995
Judit García‐Villoria Spain 24 673 1.1× 511 1.3× 135 1.0× 189 1.5× 71 0.8× 73 1.3k
Carl Fratter United Kingdom 26 945 1.6× 530 1.4× 184 1.3× 158 1.3× 109 1.2× 47 1.3k
Lisa Emrick United States 15 486 0.8× 290 0.8× 105 0.8× 134 1.1× 30 0.3× 43 736
Chike Bellarmine Item Austria 17 348 0.6× 360 0.9× 108 0.8× 179 1.4× 57 0.6× 38 879
Ayşegül Tokatlı Türkiye 17 610 1.0× 575 1.5× 116 0.8× 249 2.0× 77 0.9× 101 1.3k
Tomáš Honzík Czechia 23 1.1k 1.8× 524 1.4× 225 1.6× 233 1.9× 96 1.1× 102 1.6k

Countries citing papers authored by Mohammed Almannai

Since Specialization
Citations

This map shows the geographic impact of Mohammed Almannai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed Almannai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed Almannai more than expected).

Fields of papers citing papers by Mohammed Almannai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammed Almannai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed Almannai. The network helps show where Mohammed Almannai may publish in the future.

Co-authorship network of co-authors of Mohammed Almannai

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammed Almannai. A scholar is included among the top collaborators of Mohammed Almannai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammed Almannai. Mohammed Almannai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alfadhel, Majid, et al.. (2025). Non-Invasive Prenatal Testing in the Kingdom of Saudi Arabia: Current Status of Adoption and Roadmap for the Future. The Application of Clinical Genetics. Volume 18. 219–231.
2.
Almannai, Mohammed, Abdulrahman Alswaid, Wafaa Eyaid, et al.. (2024). Consanguinity and Occurrence of Monogenic Diseases in a Single Tertiary Centre in Riyadh, Saudi Arabia: A 2 Years Cross-Sectional Study. The Application of Clinical Genetics. Volume 17. 151–158.
3.
Alghamdi, Malak, Khalid Hundallah, Jehan Suleiman, et al.. (2023). Aromatic L-amino acid decarboxylase deficiency in countries in the Middle East: a case series and literature review. European Journal of Pediatrics. 182(6). 2535–2545.
4.
Agrawal, Pankaj B., et al.. (2023). A child with dilated cardiomyopathy and homozygous splice site variant in FLNC gene. Molecular Genetics and Metabolism Reports. 38. 101027–101027. 1 indexed citations
5.
Riedhammer, Korbinian M., et al.. (2022). Disorders of histone methylation: Molecular basis and clinical syndromes. Clinical Genetics. 102(3). 169–181. 16 indexed citations
6.
7.
Almannai, Mohammed, Lama AlAbdi, Sateesh Maddirevula, et al.. (2022). KIF26A is mutated in the syndrome of congenital hydrocephalus with megacolon. Human Genetics. 142(3). 399–405. 3 indexed citations
8.
Alfadhel, Majid, Marwan Nashabat, Ahmed Alfares, et al.. (2021). Long-term effectiveness of carglumic acid in patients with propionic acidemia (PA) and methylmalonic acidemia (MMA): a randomized clinical trial. Orphanet Journal of Rare Diseases. 16(1). 422–422. 18 indexed citations
9.
Almannai, Mohammed, et al.. (2021). Metabolic Seizures. Frontiers in Neurology. 12. 640371–640371. 22 indexed citations
10.
Almannai, Mohammed, Eissa Faqeih, Ali Alasmari, et al.. (2020). Further delineation of METTL23‐associated intellectual disability. American Journal of Medical Genetics Part A. 182(4). 785–791. 7 indexed citations
11.
Almannai, Mohammed, et al.. (2020). Clinical trials in mitochondrial disorders, an update. Molecular Genetics and Metabolism. 131(1-2). 1–13. 50 indexed citations
12.
Faqeih, Eissa, et al.. (2018). Phenotypic characterization of KCTD3‐related developmental epileptic encephalopathy. Clinical Genetics. 93(5). 1081–1086. 13 indexed citations
13.
Almannai, Mohammed, Ali Alasmari, Eissa Faqeih, et al.. (2018). Expanding the phenotype of SLC25A42‐associated mitochondrial encephalomyopathy. Clinical Genetics. 93(5). 1097–1102. 24 indexed citations
14.
Pillai, Nishitha R., Rossana Sanchez Russo, Anne O’Donnell‐Luria, et al.. (2018). Megaloblastic Anemia Progressing to Severe Thrombotic Microangiopathy in Patients with Disordered Vitamin B12 Metabolism: Case Reports and Literature Review. The Journal of Pediatrics. 202. 315–319.e2. 5 indexed citations
15.
El‐Hattab, Ayman W., Jehan Suleiman, Mohammed Almannai, & Fernando Scaglia. (2018). Mitochondrial dynamics: Biological roles, molecular machinery, and related diseases. Molecular Genetics and Metabolism. 125(4). 315–321. 116 indexed citations
16.
Almannai, Mohammed & Ayman W. El‐Hattab. (2017). Inborn Errors of Metabolism with Seizures. Pediatric Clinics of North America. 65(2). 279–299. 13 indexed citations
17.
Almannai, Mohammed, Ronit Marom, Fernando Scaglia, et al.. (2017). Milder clinical and biochemical phenotypes associated with the c.482G > A (p.Arg161Gln) pathogenic variant in cobalamin C disease: Implications for management and screening. Molecular Genetics and Metabolism. 122(1-2). 60–66. 16 indexed citations
18.
El‐Hattab, Ayman W., Mohammed Almannai, & V. Reid Sutton. (2017). Newborn Screening. Pediatric Clinics of North America. 65(2). 389–405. 42 indexed citations
19.
El‐Hattab, Ayman W., et al.. (2017). Therapies for mitochondrial diseases and current clinical trials. Molecular Genetics and Metabolism. 122(3). 1–9. 133 indexed citations
20.
Almannai, Mohammed, Ronit Marom, & V. Reid Sutton. (2016). Newborn screening: a review of history, recent advancements, and future perspectives in the era of next generation sequencing. Current Opinion in Pediatrics. 28(6). 694–699. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shlomo Almashanu Breakdown of academic impact, for papers by Zuhair N. Al‐Hassnan Breakdown of academic impact, for papers by Martin Magner Breakdown of academic impact, for papers by Ali Dursun Breakdown of academic impact, for papers by Judit García‐Villoria Breakdown of academic impact, for papers by Carl Fratter Breakdown of academic impact, for papers by Lisa Emrick Breakdown of academic impact, for papers by Chike Bellarmine Item Breakdown of academic impact, for papers by Ayşegül Tokatlı Breakdown of academic impact, for papers by Tomáš Honzík
Rankless by CCL
2026